A novel anti-B7-H3 chimeric antigen receptor from a single-chain antibody library for immunotherapy of solid cancers.
Birley K, Leboreiro-Babe C, Rota EM, Buschhaus M, Gavriil A, Vitali A, Alonso-Ferrero M, Hopwood L, Parienti L, Ferry G, Flutter B, Himoudi N, Chester K, Anderson J.
Birley K, et al. Among authors: himoudi n.
Mol Ther Oncolytics. 2022 Aug 25;26:429-443. doi: 10.1016/j.omto.2022.08.008. eCollection 2022 Sep 15.
Mol Ther Oncolytics. 2022.
PMID: 36159778
Free PMC article.